BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 24770573)

  • 1. Cognitive functioning and insight in schizophrenia and in schizoaffective disorder.
    Birindelli N; Montemagni C; Crivelli B; Bava I; Mancini I; Rocca P
    Riv Psichiatr; 2014; 49(2):77-83. PubMed ID: 24770573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Competitive employment in schizophrenia: clinical and neuropsychological correlates and quality of life].
    Birindelli N; Castagna F; Giugiario M; Graffino M; Mingrone C; Sandei L; Rocca P
    Riv Psichiatr; 2012; 47(2):89-95. PubMed ID: 22622245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premorbid adjustment in schizophrenia and schizoaffective disorder.
    Saracco-Alvarez R; Rodríguez-Verdugo S; García-Anaya M; Fresán A
    Psychiatry Res; 2009 Feb; 165(3):234-40. PubMed ID: 19162333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia.
    Goldstein G; Shemansky WJ; Allen DN
    Arch Clin Neuropsychol; 2005 Mar; 20(2):153-9. PubMed ID: 15708725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia.
    Majadas S; Olivares J; Galan J; Diez T
    Compr Psychiatry; 2012 Feb; 53(2):145-51. PubMed ID: 21621754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable.
    Gharabawi G; Bossie C; Turkoz I; Kujawa M; Mahmoud R; Simpson G
    J Nerv Ment Dis; 2007 Dec; 195(12):976-82. PubMed ID: 18091190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients.
    Bellino S; Rocca P; Patria L; Marchiaro L; Rasetti R; Di Lorenzo R; Paradiso E; Bogetto F
    J Clin Psychiatry; 2004 Jul; 65(7):908-14. PubMed ID: 15291678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.
    Kaneda Y; Jayathilak K; Meltzer HY
    Psychiatry Res; 2009 Sep; 169(2):178-9. PubMed ID: 19646764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment.
    Kaneda Y; Jayathilak K; Meltzer H
    Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia?
    Pinna F; Sanna L; Perra V; Pisu Randaccio R; Diana E; Carpiniello B;
    Riv Psichiatr; 2014; 49(1):41-9. PubMed ID: 24572583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
    Peralta V; Cuesta MJ
    J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight and neuropsychological function in patients with schizophrenia and bipolar disorder with psychotic features.
    Arduini L; Kalyvoka A; Stratta P; Rinaldi O; Daneluzzo E; Rossi A
    Can J Psychiatry; 2003 Jun; 48(5):338-41. PubMed ID: 12866340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional similarities and differences between schizophrenia, schizoaffective disorder and mania or mixed mania with mood-incongruent psychotic features.
    Pini S; de Queiroz V; Dell'Osso L; Abelli M; Mastrocinque C; Saettoni M; Catena M; Cassano GB
    Eur Psychiatry; 2004 Feb; 19(1):8-14. PubMed ID: 14969775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year follow-up of cognitive functions in schizophrenia spectrum disorders of adolescent patients treated with electroconvulsive therapy.
    de la Serna E; Flamarique I; Castro-Fornieles J; Pons A; Puig O; Andrés-Perpiña S; Lázaro L; Garrido JM; Bernardo M; Baeza I
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):611-9. PubMed ID: 22136098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of sex on cognitive insight and neurocognitive functioning in schizophrenia.
    Kao YC; Liu YP; Lien YJ; Lin SJ; Lu CW; Wang TS; Loh CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():193-200. PubMed ID: 23419242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.